BiotechTube
Home/CytoImmune Therapeutics/Michael A. Caligiuri, M.D.
MA

Michael A. Caligiuri, M.D.

Co-Founder & Chief Scientific Officer

CytoImmune Therapeutics

Therapeutic Areas

Oncology

CytoImmune Therapeutics Pipeline

DrugIndicationPhase
CAR-NK Cell TherapySolid Tumors and Hematologic MalignanciesPhase 1
CAR-NK Cell Therapy PlatformOncologyPreclinical/Clinical Development

Leadership Team at CytoImmune Therapeutics

JV
Jose Vidal, Ph.D.
Chief Operating Officer
View full CytoImmune Therapeutics profile